128 related articles for article (PubMed ID: 12188102)
1. Evidence from a population pharmacokinetics analysis for a major effect of CYP1A2 activity on inter- and intraindividual variations of clozapine clearance.
Dailly E; Urien S; Chanut E; Claudel B; Guerra N; Femandez C; Jolliet P; Bourin M
Prog Neuropsychopharmacol Biol Psychiatry; 2002 May; 26(4):699-703. PubMed ID: 12188102
[TBL] [Abstract][Full Text] [Related]
2. CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite steady-state concentrationin patients with schizophrenia.
Ozdemir V; Kalow W; Posner P; Collins EJ; Kennedy JL; Tang BK; Albers LJ; Reist C; Roy R; Walkes W; Afra P
J Clin Psychopharmacol; 2001 Aug; 21(4):398-407. PubMed ID: 11476124
[TBL] [Abstract][Full Text] [Related]
3. Semi-physiological Pharmacokinetic Model of Clozapine and Norclozapine in Healthy, Non-smoking Volunteers: The Impact of Race and Genetics.
Albitar O; Harun SN; Sheikh Ghadzi SM
CNS Drugs; 2024 Jul; 38(7):571-581. PubMed ID: 38836990
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method.
Jerling M; Merlé Y; Mentré F; Mallet A
Br J Clin Pharmacol; 1997 Nov; 44(5):447-53. PubMed ID: 9384461
[TBL] [Abstract][Full Text] [Related]
5. The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.
van der Weide J; Steijns LS; van Weelden MJ
Pharmacogenetics; 2003 Mar; 13(3):169-72. PubMed ID: 12618594
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 activity is an important determinant of clozapine dosage in schizophrenic patients.
Doude van Troostwijk LJ; Koopmans RP; Vermeulen HD; Guchelaar HJ
Eur J Pharm Sci; 2003 Dec; 20(4-5):451-7. PubMed ID: 14659489
[TBL] [Abstract][Full Text] [Related]
7. Exploring clozapine pharmacokinetics in Tunisian schizophrenic patients: A population-based modelling approach investigating the impact of genetic and non-genetic variables.
Mansour K; Fredj NB; Ammar H; Romdhane HB; Mhalla A; Chaabane A; Chadli Z; Aouam K
Basic Clin Pharmacol Toxicol; 2024 Jun; 134(6):805-817. PubMed ID: 38599832
[TBL] [Abstract][Full Text] [Related]
8. The cytochrome P450 CYP1A2 genetic polymorphisms *1F and *1D do not affect clozapine clearance in a group of schizophrenic patients.
Kootstra-Ros JE; Smallegoor W; van der Weide J
Ann Clin Biochem; 2005 May; 42(Pt 3):216-9. PubMed ID: 15949157
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine.
Jaquenoud Sirot E; Knezevic B; Morena GP; Harenberg S; Oneda B; Crettol S; Ansermot N; Baumann P; Eap CB
J Clin Psychopharmacol; 2009 Aug; 29(4):319-26. PubMed ID: 19593168
[TBL] [Abstract][Full Text] [Related]
10. Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine.
Ozdemir V; Kalow W; Okey AB; Lam MS; Albers LJ; Reist C; Fourie J; Posner P; Collins EJ; Roy R
J Clin Psychopharmacol; 2001 Dec; 21(6):603-7. PubMed ID: 11763009
[TBL] [Abstract][Full Text] [Related]
11. Clinical and genetic influencing factors on clozapine pharmacokinetics in Tunisian schizophrenic patients.
Ammar H; Chadli Z; Mhalla A; Khouadja S; Hannachi I; Alshaikheid M; Slama A; Ben Fredj N; Ben Fadhel N; Ben Romdhane H; Chaabane A; Boughattas NA; Gaha L; Zarrouk L; Aouam K
Pharmacogenomics J; 2021 Oct; 21(5):551-558. PubMed ID: 33731885
[TBL] [Abstract][Full Text] [Related]
12. Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics.
Lane HY; Chang YC; Chang WH; Lin SK; Tseng YT; Jann MW
J Clin Psychiatry; 1999 Jan; 60(1):36-40. PubMed ID: 10074876
[TBL] [Abstract][Full Text] [Related]
13. Cigarette smoking has a differential effect on the plasma level of clozapine in Taiwanese schizophrenic patients associated with the CYP1A2 gene -163A/C single nucleotide polymorphism.
Huang HC; Lua AC; Wu LS; Wu BJ; Lee SM; Liu CZ
Psychiatr Genet; 2016 Aug; 26(4):172-7. PubMed ID: 27203225
[TBL] [Abstract][Full Text] [Related]
14. Clozapine and metabolite concentrations during treatment of patients with chronic schizophrenia.
Guitton C; Kinowski JM; Abbar M; Chabrand P; Bressolle F
J Clin Pharmacol; 1999 Jul; 39(7):721-8. PubMed ID: 10392327
[TBL] [Abstract][Full Text] [Related]
15. Impact of CYP1A2 and CYP2D6 polymorphisms on drug metabolism and on insulin and lipid elevations and insulin resistance in clozapine-treated patients.
Melkersson KI; Scordo MG; Gunes A; Dahl ML
J Clin Psychiatry; 2007 May; 68(5):697-704. PubMed ID: 17503978
[TBL] [Abstract][Full Text] [Related]
16. Population pharmacokinetics of clozapine and its primary metabolite norclozapine in Chinese patients with schizophrenia.
Li LJ; Shang DW; Li WB; Guo W; Wang XP; Ren YP; Li AN; Fu PX; Ji SM; Lu W; Wang CY
Acta Pharmacol Sin; 2012 Nov; 33(11):1409-16. PubMed ID: 22820910
[TBL] [Abstract][Full Text] [Related]
17. Increased clozapine plasma concentrations and side effects induced by smoking cessation in 2 CYP1A2 genotyped patients.
Bondolfi G; Morel F; Crettol S; Rachid F; Baumann P; Eap CB
Ther Drug Monit; 2005 Aug; 27(4):539-43. PubMed ID: 16044115
[TBL] [Abstract][Full Text] [Related]
18. Clozapine pharmacokinetics and pharmacodynamics studied with Cyp1A2-null mice.
Aitchison KJ; Jann MW; Zhao JH; Sakai T; Zaher H; Wolff K; Collier DA; Kerwin RW; Gonzalez FJ
J Psychopharmacol; 2000; 14(4):353-9. PubMed ID: 11198052
[TBL] [Abstract][Full Text] [Related]
19. The effect of variable cigarette consumption on the interaction with clozapine and olanzapine.
Haslemo T; Eikeseth PH; Tanum L; Molden E; Refsum H
Eur J Clin Pharmacol; 2006 Dec; 62(12):1049-53. PubMed ID: 17089108
[TBL] [Abstract][Full Text] [Related]
20. Nonresponse to clozapine and ultrarapid CYP1A2 activity: clinical data and analysis of CYP1A2 gene.
Eap CB; Bender S; Jaquenoud Sirot E; Cucchia G; Jonzier-Perey M; Baumann P; Allorge D; Broly F
J Clin Psychopharmacol; 2004 Apr; 24(2):214-9. PubMed ID: 15206669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
